Why the study?
Does the X-Sizer thromboatherectomy device improve TIMI flow and procedural safety in patients with thrombotic lesions and diseased saphenous vein grafts?
Does the X-Sizer thromboatherectomy device improve TIMI flow and procedural safety in patients with thrombotic lesions and diseased saphenous vein grafts?
The X-Sizer thromboatherectomy device appears safe and effectively improves TIMI flow when used prior to percutaneous intervention in high-risk vein grafts and thrombotic lesions.
Answers are grounded in this paper and cite their sources.
Supports further evaluation of X-Sizer in thrombotic SVG lesions; hypothesis-generating and should not yet change practice.
Intervention in thrombotic lesions and diseased saphenous vein grafts frequently results in thromboembolic complications, including no-reflow, distal branch occlusion, periprocedural MI, and death. The utility of a novel thromboatherectomy device, the X-Sizer, was tested in 50 consecutive patients at nine U.S. centers. A total of 61 lesions were treated in 31 vein grafts and 19 native coronary arteries; thrombus was present in 78% of lesions, and TIMI 0-1 flow in 21%. TIMI 3 flow improved from 57% at baseline to 94% postprocedure. No patient developed visible distal thromboemboli, side-branch occlusion, or reduced antegrade flow. Thirty-day events included one death (2.0%), Q- or non-Q-wave MI in 4.0%, TVR in 6.0%, and any MACE in 6.0%. We conclude that the use of the X-Sizer prior to percutaneous intervention is safe in high-risk vein grafts and thrombotic lesions and results in a low rate of adverse events compared to historical controls.
No takes yet. Share an insight, caveat, or question.
Stone et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: